Trial Profile
Nephrogenic systemic fibrosis (NSF) in patients with renal disease receiving gadobenate dimeglumine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Gadobenic acid (Primary)
- Indications Renal failure
- Focus Adverse reactions
- 24 Nov 2015 New trial record